Concurrence of Gastric Cancer and Incidental Pulmonary Embolism May Be a Prognostic Factor for Advanced Gastric Cancer Patients with Incidental Pulmonary Embolism

References

• Lyman GH, Culakova E, Poniewierski MS. Morbidity, mortality and costs associated with venous thromboembolism in hospitalized patients with cancer. Thromb Res. 2018:S112–S118. doi:10.1016/j.thromres.2018.01.028.29703467
   PubMed Web of Science ®Google Scholar
• Li Y, Shang Y, Wang W, et al. Lung Cancer and pulmonary embolism: what is the relationship? A review. J Cancer. 2018;9(17):3046–3057. doi:10.7150/jca.26008.30210627
   PubMed Web of Science ®Google Scholar
• Re G, Tm P, Petterson TM, et al. Risk factors for incident venous thromboembolism in active cancer patients: a population based case-control study. Thromb Res. 2016;139:29–37. doi:10.1016/j.thromres.2016.01.00226916293
   PubMed Web of Science ®Google Scholar
• Alotaibi G, Wu C, Senthilselvan A, et al. Short- and long-term mortality after pulmonary embolism in patients with and without cancer. Vasc Med (London, England). 2018;23(3):261–266. doi:10.1177/1358863X18754692.
   PubMed Web of Science ®Google Scholar
• Yao Y, Xu QProgress in the study of cancer-associated venous thromboembolism. Vascular. 2021;29(3):408–414. doi:10.1177/170853812095744332951561
   PubMed Web of Science ®Google Scholar
• Browne AM, Cronin CG, English C, NiMhuircheartaigh J, Murphy JM, Bruzzi JF. Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thor Oncol. 2010;5(6):798–803. doi:10.1097/JTO.0b013e3181d6153a
   PubMed Web of Science ®Google Scholar
• Douma RA, Kok MG, Verberne LM, et al. Incidental venous thromboembolism in cancer patients: prevalence and consequence. Thromb Res. 2010;125(6):e306–e309. doi:10.1016/j.thromres.2010.02.01020223502
   PubMed Web of Science ®Google Scholar
• Ritchie G, McGurk S, McCreath C, Graham C, Murchison JT. Prospective evaluation of unsuspected pulmonary embolism on contrast enhanced multidetector CT (MDCT) scanning. Thorax. 2007;62(6):536–540. doi:10.1136/thx.2006.06229917158631
   PubMed Web of Science ®Google Scholar
• Tresoldi S, Flor N, Luciani A, et al. Contrast enhanced chest-MDCT in oncologic patients. Prospective evaluation of the prevalence of incidental pulmonary embolism and added value of thin reconstructions. Eur Radiol. 2015;25(11):3200–3206. doi:10.1007/s00330-015-3739-7.25899418
   PubMed Web of Science ®Google Scholar
• Chaturvedi S, Sidana S, Elson P, et al. Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer. PLoS One. 2014;9(8):e94048. doi:10.1371/journal.pone.0094048.25126949
   PubMed Web of Science ®Google Scholar
• Connolly GC, Menapace L, Safadjou S, et al.. Prevalence and clinical significance of incidental and clinically suspected venous thromboembolism in lung cancer patients. Clin Lung Cancer. 2013;14(6):713–718. doi:10.1016/j.cllc.2013.06.003.23891560
   PubMed Web of Science ®Google Scholar
• Callejas MF, Errázuriz JI, Castillo F, et al. Incidental venous thromboembolism detected by PET-CT in patients with cancer: prevalence and impact on survival rate. Thromb Res. 2014;133(5):750–755. doi:10.1016/j.thromres.2014.02.00524565275
   PubMed Web of Science ®Google Scholar
• den Exter PL, Hooijer J, Dekkers OM, et al. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients. J Clin Oncol. 2011;29(17):2405–2409. doi:10.1200/JCO.2010.34.098421555690
   PubMed Web of Science ®Google Scholar
• Bozas G, Jeffery N, Ramanujam-Venkatachala D, et al. Prognostic assessment for patients with cancer and incidental pulmonary embolism. Thromb J. 2018;16:8. doi:10.1186/s12959-017-0157-x29445314
   PubMed Web of Science ®Google Scholar
• Lyman GH, Khorana AA, Kuderer NM, et al. Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. J Oncol Pract Am Soc Clin Oncol. 2015;31(17):2189.
   Web of Science ®Google Scholar
• Kearon C, Akl EA, Ornelas J, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016;149(2):315–352.26867832
   PubMed Web of Science ®Google Scholar
• Mandalà M, Labianca R. Venous thromboembolism (VTE) in cancer patients. ESMO clinical recommendations for prevention and management. Thromb Res. 2010;S117–S119. doi:10.1016/S0049-3848(10)70028-120433989
   PubMed Web of Science ®Google Scholar
• O’connell C, Razavi P, Ghalichi M, et al. Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thrombosis Haemostasis. 2011;9(2):305–311. doi:10.1111/j.1538-7836.2010.04114.x.
   PubMed Web of Science ®Google Scholar
• Wada T, Fujiwara H, Morita S, Fukagawa T, Katai H. Incidence of and risk factors for preoperative deep venous thrombosis in patients undergoing gastric cancer surgery. Gastric Cancer. 2017;20(5):872–877. doi:10.1007/s10120-017-0690-028120128
   PubMed Web of Science ®Google Scholar
• Kimura Y, Oki E, Ando K, et al. Incidence of venous thromboembolism following laparoscopic surgery for gastrointestinal cancer: a single-center, prospective cohort study. World J Surg. 2016;40(2):309–314. doi:10.1007/s00268-015-3234-y.26316113
   PubMed Web of Science ®Google Scholar
• Tanizawa Y, Bando E, Kawamura T, et al. Prevalence of deep venous thrombosis detected by ultrasonography before surgery in patients with gastric cancer: a retrospective study of 1140 consecutive patients. Gastric Cancer. 2017;20(5):878–886. doi:10.1007/s10120-016-0677-2.27987041
   PubMed Web of Science ®Google Scholar
• Kang MJ, Ryoo BY, Ryu MH, et al. Venous thromboembolism (VTE) in patients with advanced gastric cancer: an Asian experience. Eur J Cancer. 2012;48(4):492–500. doi:10.1016/j.ejca.2011.11.01622169121
   PubMed Web of Science ®Google Scholar
• Myat Moe MM, Redla S. Incidental pulmonary embolism in oncology patients with current macroscopic malignancy: incidence in different tumour type and impact of delayed treatment on survival outcome. Br J Radiol. 2018;91(1088):20170806. doi:10.1259/bjr.20170806.29688026
   PubMed Web of Science ®Google Scholar
• Chen DY, Tseng CN, Hsieh M-J, et al. Comparison between non-vitamin K antagonist oral anticoagulants and low-molecular-weight heparin in Asian individuals with cancer-associated venous thromboembolism. JAMA Net Open. 2021;4(2):e2036304. doi:10.1001/jamanetworkopen.2020.36304
   PubMed Web of Science ®Google Scholar
• Di Nisio M, Di Nisio M, Mulder F, et al. Clinical impact of bleeding in cancer-associated venous thromboembolism: results from the Hokusai VTE cancer study. Thromb Haemost. 2018;118(8):1439–1449. doi:10.1055/s-0038-166700130060256
   PubMed Web of Science ®Google Scholar
• van Es N, van Es N, Bleker S, et al. Clinical impact and course of anticoagulant-related major bleeding in cancer patients. Thromb Haemost. 2018;118(1):174–181. doi:10.1160/TH17-04-027429304537
   PubMed Web of Science ®Google Scholar
• Gladish GW, Choe DH, Marom EM, et al. Incidental pulmonary emboli in oncology patients: prevalence, CT evaluation, and natural history. Radiology. 2006;240(1):246–255. doi:10.1148/radiol.240105112916684921
   PubMed Web of Science ®Google Scholar
• Bach AG, Schmoll HJ, Beckel C, et al. Pulmonary embolism in oncologic patients: frequency and embolus burden of symptomatic and unsuspected events. Acta Radiol. 2014;55(1):45–53. doi:10.1177/028418511349156923864061
   PubMed Web of Science ®Google Scholar
• Dg L, Lohan DG, Keane M, et al. Prevalence and significance of asymptomatic venous thromboembolic disease found on oncologic staging CT. Am J Roentgenol. 2007;189(1):162–170. doi:10.2214/AJR.07.206717579167
   PubMed Web of Science ®Google Scholar
• Khorana AA, Yannicelli D, McCrae KR, et al. Evaluation of US prescription patterns: are treatment guidelines for cancer-associated venous thromboembolism being followed? Thromb Res. 2016;145:51–53. doi:10.1016/j.thromres.2016.07.01327485998
   PubMed Web of Science ®Google Scholar
• Cha SI, Shin KM, Lim JK, et al. Pulmonary embolism concurrent with lung cancer and central emboli predict mortality in patients with lung cancer and pulmonary embolism. J Thorac Dis. 2018;10(1):262–272. doi:10.21037/jtd.2017.12.3229600056
   PubMed Web of Science ®Google Scholar
• Font C, Carmona-Bayonas A, Beato C, et al. Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study. Eur Respir J. 2017;49:1.
   Web of Science ®Google Scholar
• van Es N, Bleker, Di Nisio M. Cancer-associated unsuspected pulmonary embolism. Thromb Res. 2014;133:S172–S178. doi:10.1016/S0049-3848(14)50028-X24862140
   PubMed Web of Science ®Google Scholar
• den Exter PL, Lj K, van der Hulle T, et al. Embolic burden of incidental pulmonary embolism diagnosed on routinely performed contrast-enhanced computed tomography imaging in cancer patients. J Thrombosis Haemostasis. 2013;11(8):1620–1622. doi:10.1111/jth.12325
   PubMed Web of Science ®Google Scholar
• W S, Lee AYY, Carrier M, et al. Low-molecular-weight-heparin versus a coumarin for the prevention of recurrent venous thromboembolism in high- and low-risk patients with active cancer: a post hoc analysis of the CLOT study. J Thromb Thrombolysis. 2019;47(4):495–504. doi:10.1007/s11239-019-01833-w30859370
   PubMed Web of Science ®Google Scholar
• Di Nisio M, Lee AY, Carrier M, et al. Diagnosis and treatment of incidental venous thromboembolism in cancer patients: guidance from the SSC of the ISTH. J Thrombosis Haemostasis. 2015;13(5):880–883. doi:10.1111/jth.12883
   PubMed Web of Science ®Google Scholar
• Klok FA, Huisman MV. Management of incidental pulmonary embolism. Eur Respir J. 2017;49(6). doi:10.1183/13993003.00282-2016
   Web of Science ®Google Scholar
• Zwicker JI, Bauer KA. How long is long enough? Extended anticoagulation for the treatment of cancer-associated deep vein thrombosis. J Clin Oncol. 2014;32(32):3596. doi:10.1200/JCO.2014.56.518425267753
   PubMed Web of Science ®Google Scholar
• Khorana AA, McCrae KR, Milentijevic D, et al. Current practice patterns and patient persistence with anticoagulant treatments for cancer-associated thrombosis. Res Pract Thrombosis Haemostasis. 2017;1(1):14–22. doi:10.1002/rth2.12002
   PubMed Web of Science ®Google Scholar
• Rossel A, Robert-Ebadi H, Combescure C, et al. Anticoagulant therapy for acute venous thrombo-embolism in cancer patients: a systematic review and network meta-analysis. PLoS One. 2019;14(3):e213940. doi:10.1371/journal.pone.0213940
   PubMed Web of Science ®Google Scholar
• Choi K-J, Cha S-I, Shin K-M, et al. Central emboli rather than saddle emboli predict adverse outcomes in patients with acute pulmonary embolism. Thromb Res. 2014;134(5):991–996. doi:10.1016/j.thromres.2014.08.02725228399
   PubMed Web of Science ®Google Scholar
• Gouin B, Blondon M, Jiménez D, et al. Clinical prognosis of nonmassive central and noncentral pulmonary embolism: a registry-based cohort study. Chest. 2017;151(4):829–837. doi:10.1016/j.chest.2016.10.05627876590
   PubMed Web of Science ®Google Scholar
• Vedovati MC, Germini F, Agnelli G, et al. Prognostic role of embolic burden assessed at computed tomography angiography in patients with acute pulmonary embolism: systematic review and meta-analysis. J Thrombosis Haemostasis. 2013;11(12):2092–2102. doi:10.1111/jth.12429
   PubMed Web of Science ®Google Scholar
• Browne AM, Cronin C, English C, et al. Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thor Oncol. 2010;5(6):798–803. doi:10.1097/JTO.0b013e3181d6153a
   PubMed Web of Science ®Google Scholar
• Ikesaka R, Carrier M. Clinical significance and management of subsegmental pulmonary embolism. J Thromb Thrombolysis. 2015;39(3):311–314. doi:10.1007/s11239-015-1169-725772115
   PubMed Web of Science ®Google Scholar
• Kraaijpoel N, Bleker SM, Meyer G, et al. Treatment and long-term clinical outcomes of incidental pulmonary embolism in patients with cancer: an international prospective cohort study. J Clin Oncol. 2019;37(20):1713–1720. doi:10.1200/JCO.18.0197731116676
   PubMedGoogle Scholar
• van der Hulle T, den Exter PL, Planquette B, et al. Risk of recurrent venous thromboembolism and major hemorrhage in cancer-associated incidental pulmonary embolism among treated and untreated patients: a pooled analysis of 926 patients. J Thrombosis Haemostasis. 2016;14(1):105–113. doi:10.1111/jth.13172
   PubMed Web of Science ®Google Scholar
• Shinagare AB, Okajima Y, Oxnard GR, et al. Unsuspected pulmonary embolism in lung cancer patients: comparison of clinical characteristics and outcome with suspected pulmonary embolism. Lung Cancer. 2012;78(2):161–166. doi:10.1016/j.lungcan.2012.08.00722959241
   PubMed Web of Science ®Google Scholar